Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,471 public trials 501 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NCT06440005

Conditions
Advanced Cancer, Angiosarcoma, Breast Cancer, +46 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialist Sarasota, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Sarah Cannon Research Center Nashville, Tennessee, United States
View Trial Details
Recruiting

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

NCT05287945

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
Locations
  • Stanford Palo Alto, California, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • START Lisbon - Hospital de Santa Maria Av Lisbon, Portugal
View Trial Details
Recruiting

Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.

NCT06897644

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Centro Di Riferimento Oncologico Di Aviano Aviano, Italy
  • University Hospital Consorziale Policlinico Bari, Italy
  • Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia Brescia, Italy
  • ASST Ospedale Maggiore di Crema Crema, Italy
View all 28 locations
View Trial Details
Recruiting

Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)

NCT07016230

Conditions
Metastatic/Locally Advanced Poorly Differentiated NEC, Metastatic/Locally Advanced Small-Cell Lung Cancer, Neoplasm Metastasis, +4 more
Locations
  • Gustave Roussy Villejuif, France
  • Institut Bergonié Bordeaux, France
  • Centre Antoine Lacassagne Nice, France
View Trial Details
Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT06625775

Conditions
Advanced Breast Cancer, Advanced Lung Cancer, Breast Diseases, +35 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 44 locations
View Trial Details

Related conditions